MrktViz
    Relative StrengthThemesEarningsNewScreensNewChartsNew
    /
    Sign in
    Ratings as of Friday 20 November 2026 · updated after every US close

    Relative Strength

    An RS rating of 95 means the stock out-performed 95% of the rated stocks (William O'Neil's method). The score weights the last 3 months most (40%), then 6, 9 and 12 months (20% each), counted in trading days. Rated stocks are US common stocks and ADRs worth $300M or more, with an average price above $5 over 50 days, enough trading volume and at least 12 months of trading. This page shows who leads, who is new, who is climbing or slipping, and whether the price still looks buyable.

    2,691rated272leaders at 90+27new today25coasting
    ▲Who is risingtoday's entries, jumps and 30-day climbers
    New in the top tiers
    11 entered 95+ · 16 entered 90+
    Biggest RS jumps today
    RS points gained in one day
    30-day climbers
    often the next 90+ names
    ▼Who is slippingcoasting leaders, falling RS lines and today's biggest drops
    Coasting leaders
    25 of 272 rated 90+ on old gains
    3-month return in the bottom 40%
    Leaders losing strength
    54 of 272 fell over 30 days
    Biggest RS drops today
    RS points lost in one day
    Rated universe
    2,691 stocks
    Below 90
    2,419
    90–94
    136
    95+
    136
    The 90+ tier is one in ten stocks. Everything here focuses on it.
    How to read this page
    97 92 85 60 RS tiers: 95+, 90–94, 80–89, below 80
    Returns strip: 1m · 3m · 6m · 9m · 12m as percentiles. Green only on the right means coasting on old gains.
    Setup check: within 15% of the 52-week high, above the 50-day and the 200-day average.
    Days at 90+ counts the current unbroken streak in the leaders' tier.

    Leaders momentum

    which way the leaders are heading over 30 days
    How each tier moved over 30 days
    RS 95+136 stocks80 rising312559% up
    RS 90–94136 stocks99 rising82973% up
    ▲ Gaining fastestRS points in 30 days · now
    ▼ Fading fastestleaders whose RS fell most

    Bar = RS points gained or lost over 30 days · line = the RS rating over those days · badge = the rating now. Click a row to open it below.

    Where the leaders are

    industries by number of RS 90+ stocks · click to filter
    Industryshare of 90+StocksAvg
    Top 10 industries · green part of the bar = RS 95+ · 21 of the 272 leaders have no industry on file

    Size of the leaders

    RS 90+ stocks by market cap
    Mega (>$200B)3
    Large ($10–200B)42
    Mid ($2–10B)121
    Small (<$2B)106

    Leadership is broad when mid and small caps hold most of the 90+ list, and narrow when it sits in a few mega caps. Dark green is the 95+ share.

    Rankings

    #CompanyTrend 30d
    1MRNAModerna, Inc. Common Stock9923d+· 0· 0-30.6%1/35999999999Biological Products, (No Disgnostic Substances)1d · 030d · 0
    5TWSTTwist Bioscience Corporation Common Stock9923d+· 0· 0-53.0%1/31321979799Biological Products, (No Disgnostic Substances)1d · 030d · 0
    8KODKodiak Sciences Inc Common Stock9923d+· 0· 0-13.8%3/39499999999Biological Products, (No Disgnostic Substances)1d · 030d · 0
    18REPLReplimune Group, Inc.9923d+· 0· 0-19.0%2/39997999897Biological Products, (No Disgnostic Substances)1d · 030d · 0
    40IOVAIovance Biotherapeutics, Inc. Common Stock9823d+· 0▼ 1-55.1%1/3241969899Biological Products, (No Disgnostic Substances)1d · 030d ▼ 1
    65ADPTAdaptive Biotechnologies Corporation Common Stock9714d· 0▲ 8-13.3%3/39589999595Biological Products, (No Disgnostic Substances)1d · 030d ▲ 8
    125RLAYRelay Therapeutics, Inc. Common Stock9523d+▲ 1· 0-24.2%1/33333819598Biological Products, (No Disgnostic Substances)1d ▲ 130d · 0
    126VCELVericel Corporation9512d· 0▲ 40-3.7%3/39998969185Biological Products, (No Disgnostic Substances)1d · 030d ▲ 40
    184VORVor Biopharma Inc. Common Stock931d▲ 6▲ 50-26.2%1/37739898198Biological Products, (No Disgnostic Substances)1d ▲ 630d ▲ 50
    198EXELExelixis Inc9223d+▼ 1▲ 2-12.3%3/36995889088Biological Products, (No Disgnostic Substances)1d ▼ 130d ▲ 2
    217SRZNSurrozen, Inc. Common9216d▼ 2▲ 5-24.8%2/39295706597Biological Products, (No Disgnostic Substances)1d ▼ 230d ▲ 5
    218FENCFennec Pharmaceuticals Inc. Common Stock924d▼ 1▲ 12-5.5%3/39893899090Biological Products, (No Disgnostic Substances)1d ▼ 130d ▲ 12
    224CGONCg Oncology, Inc. Common Stock915d· 0▲ 39-15.4%2/39878858795Biological Products, (No Disgnostic Substances)1d · 030d ▲ 39
    248RVMDRevolution Medicines, Inc. Common Stock901d▲ 1▼ 6-28.1%0/32824689297Biological Products, (No Disgnostic Substances)1d ▲ 130d ▼ 6
    251KYMRKymera Therapeutics, Inc. Common Stock9020d▼ 2▲ 2-19.3%1/38364938494Biological Products, (No Disgnostic Substances)1d ▼ 230d ▲ 2
    1–15 of 15· new in its tier todayPage 1 of 1
    MrktViz

    Professional market visualization and analytics platform for traders, analysts, and financial professionals worldwide.

    Product

    • Live Data
    • Analytics
    • API Access
    • Documentation

    Company

    • About
    • Blog
    • Support
    • Contact

    © 2025 MrktViz. All rights reserved.

    Privacy PolicyTerms of Service